Cardiac Amyloidosis Likely Contributes More to Negative HFpEF Trials than Previously Thought,

Hence, the enrollment of undiagnosed HFpEF-CA patients in large clinical trials has likely contributed to the lack of positive results. A recent review by …, Hence, the enrollment of undiagnosed HFpEF-CA patients in large clinical trials has likely contributed to the lack of positive results. A recent review by …, Read More

Scroll to Top